Suspended PHASE2 INTERVENTIONAL 4-arm NCT04518319

Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic Syndrome

Clinical Comprehensive Intervention on Cognitive Impairment of Schizophrenia Patients With Metabolic Syndrome

Sponsor: Shanghai Mental Health Center

Interventions Olanzapine Omega-3 polyunsaturated fatty acids Xbox aerobic exercise transcranial direct current stimulation,tDCS

Updated 8 times since 2020 Last updated: Apr 14, 2023 Started: Oct 1, 2020 Primary completion: Nov 30, 2024 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

The COVID-19 affects the recruitment of patients.

A PHASE2 clinical study on Schizophrenia, this trial is suspended. The trial is conducted by Shanghai Mental Health Center and has accumulated 8 data snapshots since 2020. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE2
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE2
May 2023 — Jul 2024 [monthly]

Suspended PHASE2
Dec 2022 — May 2023 [monthly]

Suspended PHASE2

Status: Recruiting → Suspended
Jul 2022 — Dec 2022 [monthly]

Recruiting PHASE2

▶ Show 3 earlier versions

Oct 2021 — Jul 2022 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jan 2021 — Oct 2021 [monthly]

Not Yet Recruiting PHASE2
Sep 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Mental Health Center

Data source: Shanghai Mental Health Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China